$ALV

AUTOLIV INC

CIK:0001034670|SEC Filings

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED) - USD ($)
shares in Millions, $ in Millions

3 Months Ended

6 Months Ended

Jun. 30, 2026

Jun. 30, 2025

Jun. 30, 2026

Jun. 30, 2025

Income Statement [Abstract]

Net sales

$ 2,803

$ 2,714

$ 5,556

$ 5,292

Type of Revenue [Extensible List]

us-gaap:ProductMember

Cost of sales

^[1]

$ (2,294)

$ (2,213)

$ (4,521)

$ (4,312)

Type of Cost, Good or Service [Extensible List]

us-gaap:ProductMember

Gross profit

$ 509

$ 501

$ 1,035

$ 980

Selling, general and administrative expenses

(138)

(145)

(299)

(290)

Research, development and engineering expenses, net

(122)

(107)

(242)

(202)

Other income (expense), net

^[2]

(56)

(1)

(65)

Operating income

192

247

429

502

Income from equity method investment

Interest income

Interest expense

(26)

(27)

(53)

(52)

Other non-operating items, net

(15)

(3)

(27)

(3)

Income before income taxes

154

221

356

453

Income tax expense

(53)

(113)

(118)

Net income

^[3]

101

168

242

335

Less: Net income attributable to non-controlling interest

Net income attributable to controlling interest

$ 100

$ 167

$ 242

$ 334

Net earnings per share - basic

$ 1.35

$ 2.17

$ 3.25

$ 4.32

Net earnings per share - diluted

$ 1.35

$ 2.16

$ 3.24

$ 4.31

Weighted average number of shares outstanding, net of treasury shares (in millions)

74.1

77.1

74.3

77.3

Weighted average number of shares outstanding, assuming dilution and net of treasury shares (in millions)

74.2

77.3

74.5

77.5

Cash dividend per share - declared

^[4]

$ 0.87

$ 1.55

$ 1.74

$ 2.25

Cash dividend per share – paid

$ 0.87

$ 0.7

$ 1.74

$ 1.4

[1]	Including a gain on sale of property in China of $6 million in the first quarter of 2025. Including an impairment loss of $9 million related to the restructuring activities in Türkiye and a reversal of previously recognized supplier compensation of $13 million due to a court ruling in the second quarter of 2026.
[2]	Including a cumulative translation gain of $11 million related to the sale of the Russian entity in the first quarter of 2025.
[3]	For the three months periods ended June 30, 2026 and 2025, the aggregate transaction gain (loss) included in net income for the period was a gain of $0 million and a loss of $7 million, respectively. For the six months periods ended June 30, 2026 and 2025, the aggregate transaction gain (loss) included in net income for the period was a gain of $6 million and a loss of $14 million, respectively.
[4]	In May 2025, the Company declared a dividend per share of $0.70 for the second quarter of 2025, and in June 2025, the Company declared a dividend per share of $0.85 for the third quarter of 2025.

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions

6 Months Ended

Jun. 30, 2026

Jun. 30, 2025

Operating activities

Net income

^[1]

$ 242

$ 335

Adjustments to reconcile net income to cash provided by operating activities:

Depreciation and amortization

222

195

Deferred income taxes

(32)

(24)

Undistributed earnings from equity method investments, net of dividends

Gain on divestiture of property

(6)

Other, net

Net change in operating assets and liabilities:

Receivables (gross)

(105)

(166)

Other operating assets

(75)

(134)

(23)

(14)

Net cash provided by operating activities

359

355

Investing activities

Expenditures for property, plant and equipment

^[2]

(180)

(217)

Proceeds from sale of property, plant and equipment

Acquisition of interest in affiliates

(2)

Net cash used in investing activities

(180)

(208)

Financing activities

Net (decrease) increase in short-term debt

215

273

Proceeds from issuance of long-term debt

Repayment of long-term debt

(293)

(311)

Dividends paid

(130)

(108)

Stock repurchased

(200)

(101)

Common stock options exercised

Net cash used in financing activities

(407)

(170)

Effect of exchange rate changes on cash and cash equivalents

(71)

Decrease in cash and cash equivalents

(227)

(94)

Cash and cash equivalents at beginning of period

604

330

Cash and cash equivalents at end of period

$ 377

$ 237

[1]	For the three months periods ended June 30, 2026 and 2025, the aggregate transaction gain (loss) included in net income for the period was a gain of $0 million and a loss of $7 million, respectively. For the six months periods ended June 30, 2026 and 2025, the aggregate transaction gain (loss) included in net income for the period was a gain of $6 million and a loss of $14 million, respectively.
[2]	As of June 30, 2026 and December 31, 2025, $99 million and $104 million, respectively, of the Company's capital expenditures for property, plant and equipment during the period were included in Accounts Payable balance, and therefore represents a noncash investing activity.

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions

Jun. 30, 2026

Dec. 31, 2025

Assets

Cash and cash equivalents

$ 377

$ 604

Receivables, net

2,387

2,236

Inventories, net

945

992

Prepaid expenses and accrued income

224

212

Other current assets

Total current assets

4,009

4,101

Property, plant and equipment, net

2,340

2,417

Operating lease right-of-use assets

157

171

Goodwill and intangible assets, net

1,394

1,386

Other non-current assets

597

568

Total assets

8,497

8,644

Liabilities and equity

Short-term debt

^[1]

350

419

Accounts payable

^[2]

1,982

2,007

Accrued liabilities

1,130

1,050

Operating lease liabilities - current

Other current liabilities

394

404

Total current liabilities

3,897

3,923

Long-term debt

^[1]

1,688

1,734

Pension liability

180

169

Operating lease liabilities - non-current

110

122

Other non-current liabilities

122

113

Total non-current liabilities

2,099

2,138

Common stock

Additional paid-in capital

819

850

Retained earnings

2,251

2,308

Accumulated other comprehensive loss

^[3]

(521)

(518)

Treasury stock

(135)

(146)

Total controlling interest's equity

2,490

2,572

Non-controlling interest

Total equity

2,501

2,582

Total liabilities and equity

$ 8,497

$ 8,644

[1]	Debt as reported in balance sheet.
[2]	Amount of obligations confirmed under the Company's Supplier Finance Program that remains unpaid is reported as Accounts Payable in the Condensed Consolidated Balance Sheets. Amount of obligations outstanding as of June 30, 2026 and December 31, 2025 are $324 million and $365 million, respectively.
[3]	Including cumulative translation adjustment as of June 30, 2026 and December 31, 2025 to the amount of $(500) million and $(487) million, respectively.